ZA200610454B - Treatment or prevention of respiratory viral infections with immunomodulator compounds - Google Patents

Treatment or prevention of respiratory viral infections with immunomodulator compounds

Info

Publication number
ZA200610454B
ZA200610454B ZA200610454A ZA200610454A ZA200610454B ZA 200610454 B ZA200610454 B ZA 200610454B ZA 200610454 A ZA200610454 A ZA 200610454A ZA 200610454 A ZA200610454 A ZA 200610454A ZA 200610454 B ZA200610454 B ZA 200610454B
Authority
ZA
South Africa
Prior art keywords
prevention
treatment
viral infections
respiratory viral
immunomodulator compounds
Prior art date
Application number
ZA200610454A
Other languages
English (en)
Inventor
Cynthia W Tuthill
Alexander A Kolobov
Aleksandr V Petrov
Alfred R Rudolph
Andrey S Simbirtsev
Original Assignee
Sciclone Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sciclone Pharmaceuticals Inc filed Critical Sciclone Pharmaceuticals Inc
Publication of ZA200610454B publication Critical patent/ZA200610454B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/30—Copper compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200610454A 2004-05-14 2006-12-13 Treatment or prevention of respiratory viral infections with immunomodulator compounds ZA200610454B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57094104P 2004-05-14 2004-05-14

Publications (1)

Publication Number Publication Date
ZA200610454B true ZA200610454B (en) 2009-07-29

Family

ID=35428773

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200610454A ZA200610454B (en) 2004-05-14 2006-12-13 Treatment or prevention of respiratory viral infections with immunomodulator compounds

Country Status (17)

Country Link
US (1) US20070087974A1 (fr)
EP (1) EP1748783A4 (fr)
JP (1) JP2007537280A (fr)
KR (1) KR20070012522A (fr)
CN (1) CN1964731A (fr)
AU (1) AU2005244826B2 (fr)
BR (1) BRPI0511107A (fr)
CA (1) CA2566062A1 (fr)
EA (1) EA011954B1 (fr)
IL (1) IL179046A0 (fr)
MX (1) MXPA06013050A (fr)
NO (1) NO20065518L (fr)
NZ (1) NZ551457A (fr)
SG (1) SG169362A1 (fr)
UA (1) UA92586C2 (fr)
WO (1) WO2005112639A2 (fr)
ZA (1) ZA200610454B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA012342B1 (ru) 2004-10-27 2009-10-30 Сциклон Фармасьютикалс, Инк. Лечение или предупреждение геморрагических вирусных инфекций с помощью иммуномодулирующих соединений
US20090074815A1 (en) * 2005-04-22 2009-03-19 Sciclone Pharmaceuticals, Inc. Immunomodulator Compounds as Vaccine Enhancers
EP2120986A4 (fr) 2007-02-13 2010-04-07 Sciclone Pharmaceuticals Inc Procédé de traitement ou de prévention de la détérioration des tissus, des blessures ou des dégâts dus à une maladie de la muqueuse
RU2007118237A (ru) * 2007-05-17 2008-11-27 ООО "Научно-производственна фирма Верта" (RU) Способ лечения аллергических заболеваний
RU2438694C1 (ru) * 2010-12-23 2012-01-10 Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") Фармацевтическая композиция для лечения вирусных заболеваний
WO2024175759A1 (fr) * 2023-02-24 2024-08-29 Institut National de la Santé et de la Recherche Médicale Acide indole-3-propionique en tant que contributeur important à l'issue d'une infection virale et biomarqueur de la gravité d'une infection virale

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4766106A (en) * 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4917888A (en) * 1985-06-26 1990-04-17 Cetus Corporation Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
US5122614A (en) * 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5888980A (en) * 1994-06-30 1999-03-30 Bio-Logic Research And Development Corporation Compositions for enhancing immune function
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
US5916878A (en) * 1995-11-28 1999-06-29 Edward T. Wei γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
US5744452A (en) * 1995-11-28 1998-04-28 Edward T. Wei γ-L-glutamyl containing immunomodulator compounds and methods therewith
RU2229892C2 (ru) * 2001-06-08 2004-06-10 Государственное учреждение "Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии" Способ лечения туберкулеза легких

Also Published As

Publication number Publication date
JP2007537280A (ja) 2007-12-20
AU2005244826A1 (en) 2005-12-01
EA200602073A1 (ru) 2007-06-29
US20070087974A1 (en) 2007-04-19
MXPA06013050A (es) 2007-03-28
UA92586C2 (ru) 2010-11-25
CN1964731A (zh) 2007-05-16
BRPI0511107A (pt) 2007-11-27
AU2005244826B2 (en) 2010-07-29
KR20070012522A (ko) 2007-01-25
IL179046A0 (en) 2007-03-08
EP1748783A4 (fr) 2009-08-05
WO2005112639A3 (fr) 2006-11-09
WO2005112639A2 (fr) 2005-12-01
SG169362A1 (en) 2011-03-30
EP1748783A2 (fr) 2007-02-07
NZ551457A (en) 2009-12-24
EA011954B1 (ru) 2009-06-30
NO20065518L (no) 2006-11-29
CA2566062A1 (fr) 2005-12-01

Similar Documents

Publication Publication Date Title
EP1594512A4 (fr) Composes destines au traitement d'une infection virale
EP1951272A4 (fr) Utilisation de lactobacillus pour le traitement d'infections virales
AP2007004245A0 (en) Compounds and methods for the treatment or prevention of flavivirus infections
IL200116A0 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
AP2009005070A0 (en) Antiviral drugs for treatment or prevention of dengue infection
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
IL182785A0 (en) Particles for treatment of pulmonary infection
EP1865967A4 (fr) Composes, compositions et methodes de traitement d'infections virales et autres troubles medicaux
PT2217230T (pt) Prevenção e tratamento de infeções secundárias após infeção viral
IL178815A0 (en) The treatment of respiratory disease
ZA200803493B (en) Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection
ZA200802934B (en) Use of lactobacillus for treatment of virus infections
EP1962869A4 (fr) Traitement de maladies respiratoires
HK1124084A1 (en) Nucleic acid for treatment or prevention of immunodeficiency virus infection
GB0329254D0 (en) Treatment of viral infections
GB0410399D0 (en) The treatment of respiratory disease
ZA200610454B (en) Treatment or prevention of respiratory viral infections with immunomodulator compounds
GB2411354B (en) Use of Scutellaria for the treatment of viral infections
IL197783A0 (en) Polycyclic agents for the treatment of respiratory syncytial virus infections
PL2132215T3 (pl) Związki do zapobiegania lub leczenia zakażeń wirusowych i sposoby ich stosowania
GB2441094B (en) Methods for treatment and prevention of infection
EP1838216A4 (fr) Prevention d'infections respiratoires chez la volaille
EP2160191A4 (fr) Suppression de virus impliqués dans une maladie ou une infection respiratoire
ZA200800201B (en) Composition and the use thereof for the treatment of viral infections
GB201010682D0 (en) Methods for treatment and prevention of infection